1887

Microbiology Society logo

Volume 154, Issue 4

Age-related genotypic and phenotypic differences in isolates from children and adults presenting with respiratory disease in 2001–2002 Free

Abstract

is generally associated with upper respiratory tract infections in children and lower respiratory tract infections in adults. However, little is known regarding the population biology of isolates infecting these two age groups. To address this, a population-screening strategy was employed to investigate 195 worldwide isolates cultured from children (<5 years of age) and adults (>20 years of age) presenting with respiratory disease in the years 2001–2002. Parameters compared included: genotype analysis; autoagglutination/biofilm-forming ability; serum resistance; , , , and incidence; /LOS//16S rRNA types; and UspA1/Hag expression. A significant difference in biofilm formation (=0.002), but not in autoagglutination or serum resistance, was observed, as well as significant differences in the incidence of - and -positive isolates, and the distribution of lipooligosaccharide (LOS) types (<0.0001 and =0.01, respectively). Further, a significant decrease in the incidence of Hag expression (for isolates possessing the gene) was observed in adult isolates (=0.001). Both and LOS type B were associated with 16S rRNA type 1 isolates only, and two surrogate markers ( and PCR RFLP types) for the two major 16S rRNA genetic lineages were identified. In conclusion, there are significant differences in phenotype and gene incidence between isolates from children and adults presenting with respiratory disease, possibly as a result of immune evasion in the adult age group. Our results should also be useful in the choice of effective vaccine candidates against .

  • Received:
  • Accepted:
  • Revised:
  • Published Online:
Keyword(s): LOS, lipooligosaccharide
SGM
Loading

Article metrics loading...

/content/journal/micro/10.1099/mic.0.2007/015057-0
2008-04-01
2024-04-19
Loading full text...

Full text loading...

/deliver/fulltext/micro/154/4/1178.html?itemId=/content/journal/micro/10.1099/mic.0.2007/015057-0&mimeType=html&fmt=ahah

References

  1. Aebi C., Lafontaine E. R., Cope L. D., Latimer J. L., Lumbley S. L., McCracken G. H. Jr, Hansen E. J. 1998; Phenotypic effect of isogenic uspA1 and uspA2 mutations on Moraxella catarrhalis 035E. Infect Immun 66:3113–3119
     [Google Scholar]
  2. Ahmad S. 1998; Bronchopulmonary infection due to Moraxella ( Branhamella) catarrhalis at a specialist hospital in Saudi Arabia. J Commun Dis 30:233–236
     [Google Scholar]
  3. Akgul G., Erturk A., Turkoz M., Turan T., Ichinose A., Nagatake T., Ahmed K. 2005; Role of lipooligosaccharide in the attachment of Moraxella catarrhalis to human pharyngeal epithelial cells. Microbiol Immunol 49:931–935
     [Google Scholar]
  4. Akimana C., Lafontaine E. R. 2007; The Moraxella catarrhalis outer membrane protein CD contains two distinct domains specifying adherence to human lung cells. FEMS Microbiol Lett 271:12–19
     [Google Scholar]
  5. Attia A. S., Ram S., Rice P. A., Hansen E. J. 2006; Binding of vitronectin by the Moraxella catarrhalis UspA2 protein interferes with late stages of the complement cascade. Infect Immun 74:1597–1611
     [Google Scholar]
  6. Bakri F., Brauer A. L., Sethi S., Murphy T. F. 2002; Systemic and mucosal antibody response to Moraxella catarrhalis after exacerbations of chronic obstructive pulmonary disease. J Infect Dis 185:632–640
     [Google Scholar]
  7. Bootsma H. J., van der Heide H. G., van de Pas S., Schouls L. M., Mooi F. R. 2000; Analysis of Moraxella catarrhalis by DNA typing: evidence for a distinct subpopulation associated with virulence traits. J Infect Dis 181:1376–1387
     [Google Scholar]
  8. Edwards K. J., Schwingel J. M., Datta A. K., Campagnari A. A. 2005; Multiplex PCR assay that identifies the major lipooligosaccharide serotype expressed by Moraxella catarrhalis clinical isolates. J Clin Microbiol 43:6139–6143
     [Google Scholar]
  9. Faden H. 1995; Comparison of the local immune response to nontypable Haemophilus influenzae (nHI) and Moraxella catarrhalis (MC) during otitis media. Adv Exp Med Biol 371B:733–736
     [Google Scholar]
  10. Faden H., Harabuchi Y., Hong J. J. 1994; Epidemiology of Moraxella catarrhalis in children during the first 2 years of life: relationship to otitis media. J Infect Dis 169:1312–1317
     [Google Scholar]
  11. Fergie N., Bayston R., Pearson J. P., Birchall J. P. 2004; Is otitis media with effusion a biofilm infection?. Clin Otolaryngol Allied Sci 29:38–46
     [Google Scholar]
  12. Gil-Turnes C. 1983; Hemagglutination, autoagglutination and pathogenicity of Moraxella bovis strains. Can J Comp Med 47:503–504
     [Google Scholar]
  13. Hol C., Schalen C., Verduin C. M., Van Dijke E. E., Verhoef J., Fleer A., Van Dijk H. 1996; Moraxella catarrhalis in acute laryngitis: infection or colonization?. J Infect Dis 174:636–638
     [Google Scholar]
  14. Janicka G., Mikucka A., Sekowska A., Zwierzchlewski T., Wroblewski M. 2002; Autoaggregation, hydrophobic, and hydrophylic properties of Moraxella catarrhalis strains. Acta Microbiol Pol 51:23–30
     [Google Scholar]
  15. Kapperud G., Lassen J. 1983; Relationship of virulence-associated autoagglutination to hemagglutinin production in Yersinia enterocolitica and Yersinia enterocolitica-like bacteria. Infect Immun 42:163–169
     [Google Scholar]
  16. Kobayashi Y. 2000; Bacteremic Moraxella catarrhalis pneumonia. J Infect Chemother 6:68
     [Google Scholar]
  17. Lipski S. L., Holm M. M., Lafontaine E. R. 2007a; Identification of a Moraxella catarrhalis gene that confers adherence to various human epithelial cell lines in vitro. FEMS Microbiol Lett 267:207–213
     [Google Scholar]
  18. Lipski S. L., Akimana C., Timpe J. M., Wooten R. M., Lafontaine E. R. 2007b; The Moraxella catarrhalis autotransporter McaP is a conserved surface protein that mediates adherence to human epithelial cells through its N-terminal passenger domain. Infect Immun 75:314–324
     [Google Scholar]
  19. Liu D. F., Xie X., Mastri M. G., Fortuna-Nevin M., Colocillo C., Fletcher L., Dilts D. A., McMichael J. C., Baker S. M. 2006; Polymorphism of the major surface epitope of the CopB outer membrane protein of Moraxella catarrhalis. FEMS Immunol Med Microbiol 47:343–350
     [Google Scholar]
  20. Luke N. R., Howlett A. J., Shao J., Campagnari A. A. 2004; Expression of type IV pili by Moraxella catarrhalis is essential for natural competence and is affected by iron limitation. Infect Immun 72:6262–6270
     [Google Scholar]
  21. Luke N. R., Jurcisek J. A., Bakaletz L. O., Campagnari A. A. 2007; Contribution of Moraxella catarrhalis type IV pili to nasopharyngeal colonization and biofilm formation. Infect Immun 75:5559–5564
     [Google Scholar]
  22. Manfredi R., Nanetti A., Valentini R., Chiodo F. 2000; Moraxella catarrhalis pneumonia during HIV disease. J Chemother 12:406–411
     [Google Scholar]
  23. Meier P. S., Troller R., Grivea I. N., Syrogiannopoulos G. A., Aebi C. 2002; The outer membrane proteins UspA1 and UspA2 of Moraxella catarrhalis are highly conserved in nasopharyngeal isolates from young children. Vaccine 20:1754–1760
     [Google Scholar]
  24. Meier P. S., Freiburghaus S., Martin A., Heiniger N., Troller R., Aebi C. 2003; Mucosal immune response to specific outer membrane proteins of Moraxella catarrhalis in young children. Pediatr Infect Dis J 22:256–262
     [Google Scholar]
  25. Misawa N., Blaser M. J. 2000; Detection and characterization of autoagglutination activity by Campylobacter jejuni. Infect Immun 68:6168–6175
     [Google Scholar]
  26. Murphy T. F., Kirkham C., Liu D. F., Sethi S. 2003; Human immune response to outer membrane protein CD of Moraxella catarrhalis in adults with chronic obstructive pulmonary disease. Infect Immun 71:1288–1294
     [Google Scholar]
  27. Murphy T. F., Brauer A. L., Grant B. J., Sethi S. 2005a; Moraxella catarrhalis in chronic obstructive pulmonary disease: burden of disease and immune response. Am J Respir Crit Care Med 172:195–199
     [Google Scholar]
  28. Murphy T. F., Brauer A. L., Aebi C., Sethi S. 2005b; Identification of surface antigens of Moraxella catarrhalis as targets of human serum antibody responses in chronic obstructive pulmonary disease. Infect Immun 73:3471–3478
     [Google Scholar]
  29. Murphy T. F., Brauer A. L., Aebi C., Sethi S. 2005c; Antigenic specificity of the mucosal antibody response to Moraxella catarrhalis in chronic obstructive pulmonary disease. Infect Immun 73:8161–8166
     [Google Scholar]
  30. N'Guessan P. D., Vigelahn M., Bachmann S., Zabel S., Opitz B., Schmeck B., Hippenstiel S., Zweigner J., Riesbeck K. other authors 2007; The UspA1 protein of Moraxella catarrhalis induces CEACAM-1-dependent apoptosis in alveolar epithelial cells. J Infect Dis 195:1651–1660
     [Google Scholar]
  31. Pearson M. M., Hansen E. J. 2007; Identification of gene products involved in biofilm production by Moraxella catarrhalis ETSU-9 in vitro. Infect Immun 75:4316–4325
     [Google Scholar]
  32. Pearson M. M., Lafontaine E. R., Wagner N. J., St Geme J. W. III, Hansen E. J. 2002; A hag mutant of Moraxella catarrhalis strain O35E is deficient in hemagglutination, autoagglutination, and immunoglobulin D-binding activities. Infect Immun 70:4523–4533
     [Google Scholar]
  33. Pearson M. M., Laurence C. A., Guinn S. E., Hansen E. J. 2006; Biofilm formation by Moraxella catarrhalis in vitro: roles of the UspA1 adhesin and the Hag hemagglutinin. Infect Immun 74:1588–1596
     [Google Scholar]
  34. Schmitz F. J., Beeck A., Perdikouli M., Boos M., Mayer S., Scheuring S., Kohrer K., Verhoef J., Fluit A. C. 2002; Production of BRO β-lactamases and resistance to complement in European Moraxella catarrhalis isolates. J Clin Microbiol 40:1546–1548
     [Google Scholar]
  35. Sethi S., Surface J. M., Murphy T. F. 1997; Antigenic heterogeneity and molecular analysis of CopB of Moraxella ( Branhamella) catarrhalis. Infect Immun 65:3666–3671
     [Google Scholar]
  36. Vaneechoutte M., Verschraegen G., Claeys G., Van Den Abeele A. M. 1990; Serological typing of Branhamella catarrhalis strains on the basis of lipopolysaccharide antigens. J Clin Microbiol 28:182–187
     [Google Scholar]
  37. Verduin C. M., Hol C., Van Dijke E., Faber J. A., Jansze M., Verhoef J., Van Dijk H. 1995; Assessment of complement-mediated killing of Moraxella ( Branhamella) catarrhalis isolates by a simple method. Clin Diagn Lab Immunol 2:365–368
     [Google Scholar]
  38. Verduin C. M., Kools-Sijmons M., van der Plas J., Vlooswijk J., Tromp M., van Dijk H., Banks J., Verbrugh H., van Belkum A. 2000; Complement-resistant Moraxella catarrhalis forms a genetically distinct lineage within the species. FEMS Microbiol Lett 184:1–8
     [Google Scholar]
  39. Vlastarakos P. V., Nikolopoulos T. P., Maragoudakis P., Tzagaroulakis A., Ferekidis E. 2007; Biofilms in ear, nose, and throat infections: how important are they?. Laryngoscope 117:668–673
     [Google Scholar]
  40. Wang W., Pearson M. M., Attia A. S., Blick R. J., Hansen E. J. 2007; A UspA2H-negative variant of Moraxella catarrhalis strain O46E has a deletion in a homopolymeric nucleotide repeat common to uspA2H genes. Infect Immun 75:2035–2045
     [Google Scholar]
  41. Wirth T., Morelli G., Kusecek B., van Belkum A., van der Schee C., Meyer A., Achtman M. 2007; The rise and spread of a new pathogen: seroresistant Moraxella catarrhalis. Genome Res 17:1647–1656
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/micro/10.1099/mic.0.2007/015057-0
Loading
Age-related genotypic and phenotypic differences in Moraxella catarrhalis isolates from children and adults presenting with respiratory disease in 2001–2002
Microbiology 154, 1178 (2008); https://doi.org/10.1099/mic.0.2007/015057-0
/content/journal/micro/10.1099/mic.0.2007/015057-0
/content/journal/micro/10.1099/mic.0.2007/015057-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error